Investing

Today's Market Winners and Losers

Photo by Spencer Platt/Getty Images
The market is down Thursday over concerns on China’s GDP growth, which could not be offset by a drop in jobless benefit applications. The Dow Jones Industrial Average is down 0.77%, the NASDAQ is down 1.60% and the S&P 500 is down 1.07%. Today’s lone winner was a pharmaceutical company which entered into an agreement to provide a new drug, while weak earnings reports beat up today’s two losers.

Here are today’s market winners and losers.

Biggest Winners

Shares of Affymax (NASDAQ: AFFY) are up 12.12% to $13.41 on trading volume of 1.3 million shares. The company announced Thursday it has entered into a nine-month supply agreement with Takeda to provide the OMONTYS Injection to Fresenius Medical Care North America. The 52-week high is $16.25.

Biggest Losers

Shares of Supervalu (NYSE: SVU) are down 43.29% to $3.00 based on trading volume of 35.3 million shares. The groery store chain’s earnings per share in the first quarter were 19 cents, well short of 38 cents analysts polled by Thomson Reuters expected. The firm also said it was suspending its dividend and would consider selling the company. Before Thursday, the 52-week low was $4.05

Shares of InfoSys (NASDAQ: INFY) are down 12.57% to $38.56 on trading volume of 4.6 million shares. Revenue in the first quarter was $1.75 billion, slightly lower than $1.77 billion Wall Street analysts polled by Thomson Reuters were expecting. Before Thursday, the 52-week low was $41.40.

Samuel Weigley

Credit card companies are handing out rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.